SINGAPORE - Mobile-health Network Solutions (NASDAQ:MNDR), also known as MaNaDr, an Asia-Pacific leader in telehealth, has announced the establishment of a subsidiary in Malaysia, marking a significant step in its expansion strategy. This move is aimed at addressing the growing healthcare needs in Southeast Asia by providing accessible and affordable telemedicine services.
The Malaysian subsidiary is part of MNDR's efforts to strengthen its regional presence and enhance its brand recognition. By offering services tailored to the Malaysian healthcare environment, the company aims to ensure that patients receive care that is both effective and compliant with local regulations.
The rise of chronic diseases such as diabetes and hypertension in Southeast Asia poses a challenge to healthcare systems, and MNDR's telemedicine platform is positioned to play a key role in improving the management of these conditions. The platform facilitates remote consultations and medication management, which can lead to better patient outcomes and reduced strain on traditional healthcare facilities.
Co-CEO Dr. Rachel Teoh Pui Pui, PBM, emphasized the platform's commitment to patient well-being and high-quality care led by medical professionals. Co-CEO Dr. Siaw Tung Yeng, PBM, highlighted the potential for telemedicine services to offer a more affordable alternative for managing chronic conditions and receiving preventive care in Malaysia.
Mobile-health Network Solutions is the first telehealth provider from the region to be listed in the US. Its MaNaDr platform connects healthcare providers with users globally, offering a range of telehealth solutions including teleconsultation and prescription fulfillment.
The company's expansion into Malaysia is set to bridge gaps in healthcare access and affordability, with the potential to contribute to a healthier Southeast Asian population.
The information in this article is based on a press release statement.
InvestingPro Insights
As Mobile-health Network Solutions (NASDAQ:MNDR) forges ahead with its expansion in Southeast Asia, the company's financial and market performance offers a mixed picture. The InvestingPro Tips highlight that management has been proactively engaging in share buybacks, which could be a signal of confidence in the company's value. Additionally, MNDR is noted for its high shareholder yield, which may appeal to investors seeking returns from their investments. On the other hand, the stock has experienced significant price volatility and has faced a notable decline over recent periods, with analysts not expecting profitability within this fiscal year.
Delving into the InvestingPro Data, MNDR's Price to Earnings (P/E) Ratio stands at -24.23, indicating that the company has been operating at a loss in the last twelve months as of Q4 2023. The Price to Book (P/B) ratio is also negative at -212.04, which may raise concerns about the company's valuation relative to its net assets. However, the company has seen revenue growth of 12.68% over the last twelve months, showing some positive momentum in its business operations. The Gross Profit Margin is reported at 13.9%, suggesting that while the company is generating profit on its sales, it still faces challenges in translating these into net earnings.
For readers looking to delve deeper into MNDR's financial health and market performance, there are additional InvestingPro Tips available at https://www.investing.com/pro/MNDR. There are 11 more tips that could provide valuable insights, especially for those considering an investment in the telehealth sector. To enhance your research experience, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription to InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.